期刊文献+

经直肠内线圈三维氢质子磁共振波谱诊断前列腺癌的临床价值

Three dimensional proton magnetic resonance spectroscopy with an endorectal coil in the diagnosis of prostate cancer
原文传递
导出
摘要 目的探讨经直肠内线圈三维氢质子磁共振波谱(3D 1H-MRS)诊断前列腺癌的临床价值。方法回顾性分析40例经病理证实的前列腺癌患者资料。采用高分辨MR T2WI和波谱扫描,由2名不知道患者临床和组织学资料的医师对扫描结果进行评价,对比分析前列腺癌MR T2WI和3D1H-MRS的特点。结果前列腺癌区(胆碱+肌酸)/枸橼酸盐平均值为1.98±1.13,周围正常前列腺组织为0.61±0.16.组间比较差异有统计学意义(P<0.05)。MR T2WI检出前列腺癌29例,准确率72.5%,3D 1H-MRS检出前列腺癌35例,准确率87.5%,二者比较差异有统计学意义(P<0.05)。结论3D 1H-MRS诊断前列腺癌准确性高于MR,前列腺癌组织分化程度可影响MRS测定的代谢物浓度或浓度比值。与前列腺癌组织分化程度相对照的大样本研究将有利于MRS中胆碱十肌酸/枸橼酸盐阈值的确定、癌肿恶性程度和外侵趋势的评估。 To evaluate the diagnostic value of endorectal 3D 1H magnetic resonance (MR) spectroscopic imaging on prostate cancer. Methods This was a retrospective study of 40 patients with pathology-- proved prostate cancer. Transverse high-spatial-resolution T2-weighted MR imaging and MR spectroscopic images were analyzed. The MR examinations were evaluated by two radiologists and the MR and 3D 1 H MRS findings were compared. Results The ratio of citrate to creatine plus choline was 1.98± 1. 13 in the regions of cancer and 0. 61 ± 0. 16 in the regions of normal prostate tissue. The difference in ratios between cancer and normal prostate tissue was statistically significant (P〈0.01). The MR T2WI scan showed a sensitivity of 72.5% (29/40). 3D 1 H-MRS obtained a sensitivity of 87.5%(35/40). Conclusions The 3D 1 H-MRS improves the reliability of endorectal MR in the diagnosis and characterization of prostatic cancer. Larger sample study corresponding with histological differentiation of prostatic cancer might help the threshold determination of the creatine+choline/ citrate, evaluation of tumor grade and the prediction of extracapsular extension.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2007年第8期548-551,共4页 Chinese Journal of Urology
关键词 前列腺肿瘤 磁共振波谱学 Prostatic neoplasms Carcinoma Magnetic resonance spectroscopy
  • 相关文献

参考文献11

  • 1Kaji Y, Wada A, Imaoka I, et al. Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: external surface coil vs. endorectal surface coil. J Magn Reson Imaging, 2002,16 : 697-706. 被引量:1
  • 2Punglia RS, D'Amico AV, Catalona WJ,et al. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med, 2003, 349: 335- 342. 被引量:1
  • 3Obek C, Louis P, Civantos F, et al. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. J Urol,1999,161:494-498. 被引量:1
  • 4Males RG, Vigneron DB, StarLack J, et al. Clinical applications of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer stagingl and localization by in vivo 3D H mag-netic resonance spectroscopic imaging. Magn Reson Med, 2000,43 : 17-22. 被引量:1
  • 5王霄英,周良平,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.RS对中国人前列腺癌鉴别诊断标准的初步研究[J].中国医学影像技术,2004,20(8):1150-1153. 被引量:97
  • 6Casciani E, Polettini E, Bertini L, et al. Prostate cancer evaluation with endorectal MR inaging and Three-dimensional proton MRS imaging. Radiol Med, 2004,108 : 530-41. 被引量:1
  • 7Liney GP, Turnbull LW, Lowry M, et al. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. Magn Reson Imaging, 1997,15: 1177-86. 被引量:1
  • 8Rajeev K, AE Mahesh, Kumar AE, et al. Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate. Urol Res, 2004,32 ; 36-40. 被引量:1
  • 9Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology, 1999, 213:473-480. 被引量:1
  • 10Wefer AE, Hricak H, Vigneron DB, et al. Sextant localization of prostate cancer: Comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step-section histology. J Urol, 2000, 164: 400- 404. 被引量:1

二级参考文献8

  • 1[1]Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR imaging of the in situ human prostate with high (0.24-0.7 cm3) spatial resolution[J]. Radiology, 1996, 198(3): 795-805. 被引量:1
  • 2[2]Cornud F, Flam T, Chauveinc, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results[J]. Radiology, 2002, 224(1): 203-210. 被引量:1
  • 3[5]Bartolozzi C, Crocetti L, Menchi I, et al. Endorectal magnetic resonance imaging in local staging of prostate carcinoma[J]. Abdom Imaging, 2001, 26(2): 111-122. 被引量:1
  • 4[6]Lowry M, Liney GP, Turnbull LW, et al. Quantification of citrate concentration in the prostate by proton magnetic spectroscopy: zonal and age-related differences[J]. Magn Reson Med, 1996, 36(3): 252-358. 被引量:1
  • 5[7]Kurhanewicz J, Swanson MG, Wood PJ, et al. Magnetic resonance imaging and spectroscopic imaging: improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials[J]. Urology, 2001, 57(suppl 4A): 124-128. 被引量:1
  • 6[8]Hahn P, Smith ICP, Leboldus L, et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra[J]. Cancer Research, 1997, 57(6): 3398-3401. 被引量:1
  • 7[9]Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings[J]. Radiology, 1989, 172(1): 131-137. 被引量:1
  • 8[10]Muramoto S, Uematsu H, Kimura H, et al. Differential of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging[J]. Euro J Radio, 2002, 44(1): 52-58. 被引量:1

共引文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部